From: Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital
Variable | Diabetes Mellitus | |
---|---|---|
Type 1, n = 117 | Type 2, n = 546 | |
Time between the first and last teleconsultation | ||
< 6 months | 19 (16,2) | 99 (18,1) |
≥ 6 months | 52 (44,4) | 217 (39,7) |
ND (Patients with only one teleconsultation evaluation) | 46 (39,3) | 230 (42,1) |
Glycosylated hemoglobin, %* | ||
First teleconsultation | 7.7 (7-8.7) | 6.6 (6.1–7.3) |
Last teleconsultation | 7.5 (7-8.67) | 6.6 (6.1–7.3) |
LDL cholesterol, mg/dL* | ||
First teleconsultation | 99 (82–122) | 82 (59–116) |
Last teleconsultation | 102 (75–123) | 77 (57–103) |
HDL cholesterol, mg/dL* | ||
First teleconsultation | 62 (49–73) | 45 (37–53) |
Last teleconsultation | 56 (50–70) | 45 (38–53) |
Triglycerides, mg/dL* | ||
First teleconsultation | 86.5 (57–112) | 140 (104–189) |
Last teleconsultation | 88 (62–100) | 133 (96–163) |
Creatinine, mg/dL* | ||
First teleconsultation | 0.745 (0.6–0.92) | 0.865 (0.7–1.06) |
Last teleconsultation | 0.8 (0.73–0.93) | 0.89 (0.76–1.08) |
Microalbuminuria, mg/L* | ||
First teleconsultation | 5.2 (3-16.5) | 7.5 (3.6–28) |
Last teleconsultation | 10.2 (4.4–19.5) | 10 (4.4–31) |